More new Ottawa jobs in healthcare sector

More jobs leads to a need for more housing, which leads to an increase in housing values.....

Canadian scientists have received $11 million to advance research into cancer immunotherapy, much of it conducted in Ottawa, including a promising treatment that uses genetically modified immune cells to fight leukemia and other blood cancers.

The funding, announced Wednesday by the federally funded BioCanRx network, is designed to build both the scientific and manufacturing capacity required to launch Canadian-based human clinical trials of CAR-T cell therapy.

The therapy involves re-engineering a patient’s own T cells to make them better cancer fighters.

Ottawa researchers will receive $5.5 million in grants and Ottawa will become home to a multimillion-dollar manufacturing centre capable of producing a key component of CAR-T cells.

for the complete article please click here